Free shipping on all orders over $ 500

Zimlovisertib

Cat. No. M8100

All AbMole products are for research use only, cannot be used for human consumption.

Zimlovisertib Structure
Synonym:

PF06650833; PF 6650833

Size Price Availability Quantity
10mM*1mL in DMSO USD 80 In stock
1mg USD 35 In stock
5mg USD 75 In stock
10mg USD 135 In stock
50mg USD 600 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PF06650833 is an inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4). IRAK4 kinase is important in innate immunity, involved in initiating signaling from Toll-like receptors and members of th einterleukin-1 receptor family. IRAK4 kinase is an attractive target for the treatment of various diseases associated with deregulated inflammation, such as rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and systemic lupus erythematosus. PF06650833 has been investigated for treatment of lupus.

Product Citations
Chemical Information
Molecular Weight 361.37
Formula C18H20FN3O4
CAS Number 1817626-54-2
Solubility (25°C) DMSO ≥ 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Satomi Matsuoka, et al. Myeloid differentiation factor 88 signaling in donor T cells accelerates graft- versus-host disease

[2] Spencer I Danto, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects

[3] Chao-Yang Lai, et al. Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation

Related IRAK Products
CA-4948

CA-4948 is a selective, potent and orally active inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) that regulates IRAK4 function in the TLR and IL-1R signaling cascades. CA-4948 has good pharmacokinetic characteristics and antitumor activity in vitro and in vivo.

AS 2444697

AS 2444697 is a potent and selective IRAK4 inhibitor.

IRAK-1-4 Inhibitor I

IRAK-1-4 Inhibitor I is an inhibitor of interleukin-1 receptor-associated kinase 1/4 (IRAK 1/4) with IC50s of 0.3 μM and 0.2 μM, respectively.

Zabedosertib

Zabedosertib (BAY 1834845) is a selective, orally potent IRAK4 inhibitor with immunomodulatory and anti-inflammatory activity and an IC50 value of 3.55 nM. Zabedosertib (BAY 1834845) exhibits anti-inflammatory property against IL-β, LPS and Imiquimod induced inflammation.

IRAK4-IN-4

IRAK4-IN-4 is an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor with an IC50 of 2.8 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Zimlovisertib, PF06650833; PF 6650833 supplier, IRAK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.